2. Protein Tyrosine Kinase/RTK Apoptosis
  3. DYRK Apoptosis
  4. JH-XVII-10

JH-XVII-10 是一种有效的，具有选择性和口服活性的 DYRK1A 和 DYRK1B 抑制剂，IC50值分别为 3 nM 和 5 nM。JH-XVII-10 在颈部鳞状细胞癌 (HNSCC) 细胞系中显示出抗肿瘤功效。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

JH-XVII-10 Chemical Structure

JH-XVII-10 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

JH-XVII-10 相关抗体

Top Publications Citing Use of Products

查看 DYRK 亚型特异性产品:

查看所有亚型
DYRK1 DYRK2 DYRK3 DYRK4

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

JH-XVII-10 is a potent, selective and orally active DYRK1A and DYRK1B inhibitor with IC50s of 3 nM and 5 nM for DYRK1A and DYRK1B, respectively. JH-XVII-10 shows antitumor efficacy in neck squamous cell carcinoma (HNSCC) cell lines[1].

IC50 & Target[1]

DYRK1A

3 nM (IC50)

DYRK1B

5 nM (IC50)

体外研究
(In Vitro)

JH-XVII-10 (compound 10) (1 µM; CAL27 cells) shows active against JNK1 (IC50=1130 nM), JNK2 (IC50=1100 nM), JNK3 (IC50=>10 000 nM), FAK (IC50=90 nM), RSK1 (IC50=82 nM), RSK2 (IC50=80 nM), RSK3 (IC50=61 nM)[1].
JH-XVII-10 (10 µM; 72 h) decreases cell proliferation by ~45%, and ~40% for CAL27 and FaDu cells, respectively[1].
JH-XVII-10 (1, 10 µM; 24 h) induces apoptosis in CAL27 cells[1].
JH-XVII-10 (0.5, 1, 5, 10 µM; 24 h) shows inhibitory effects on pro-tumor signaling in CAL27 cells[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

JH-XVII-10 相关抗体:

Cell Proliferation Assay[1]

Cell Line: CAL27, FaDu, HEK293FT cells
Concentration: 10 µM
Incubation Time: 72 h
Result: Decreased cell proliferation by ~45%, and ~40% for CAL27 and FaDu cells, respectively.

Western Blot Analysis[1]

Cell Line: CAL27 cells
Concentration: 0.5, 1, 5, 10 µM
Incubation Time: 24 h
Result: Showed inhibitory effects on pro-tumor signaling.

Apoptosis Analysis[1]

Cell Line: CAL27 cells
Concentration: 1, 10 µM
Incubation Time: 24 h
Result: Induced increases in the proapoptotic marker (cleaved PARP), and decreased the expression of antiapoptotic protein BCL-xL.
体内研究
(In Vivo)

JH-XVII-10 (2 mg/kg, i.v.; 10 mg/kg, p.o.) shows oral bioavailability (F=12%)[1]. Pharmacokinetic Parameters of JH-XVII-10 in C57Bl/6 male mice[1].

administration parameters rat dog
i.v. T1/2 (h) 1.4±0.3 5.70±1.2
AUC0-∞ (ng*h/mL) 931.3±95.7 14,830.8±5475.4
CL (mL/min/kg) 17.6±2.0 149.9±62.5
Vss (L/kg) 1.7±0.2 828.7±134.2
p.o. Cmax (ng/mL) 1661.1±916.6 3979.4±483.5
Tmax(h) 0.9±0.8 1.3±0.5
T1/2 (h) 1.4±0.2 4.9±0.6
AUC0-∞ (ng*h/mL) 5044.9±1061 23,109.9±7752.2
F (%) 54.2 31.8
C57Bl/6 male mice; 2 mg/kg, i.v.; 10 mg/kg, p.o.[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57Bl/6 male mice[1]
Dosage:
Administration: 2 mg/kg, i.v.; 10 mg/kg, p.o.
Result: Showed oral bioavailability (F=12%).
分子量

486.42

Formula

C22H18F4N8O
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

JH-XVII-10 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

JH-XVII-10DYRKApoptosisDual specificity tyrosine phosphorylation regulated kinaseDual specificity tyrosine regulated kinasecancerselectivemacrocyclic kinase inhibitorsorally activeCAL27 cellsapoptosisInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
JH-XVII-10
目录号：
HY-144614
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z